News
Andrew Meehan. It's been 20 years since Hillenkamp and Karas developed MALDI. In that time, the soft ionization method, coupled with time-of-flight (TOF) mass spectrometry, has distinguished itself as ...
Bruker's (BRKR) neofleX is a versatile, high-performance and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers.
MALDI-TOF/TOF Mass Spectrometer. Perhaps no tool has been as instrumental to the proteomics revolution as the mass spectrometer. With the ability to deconvolute highly complex mixtures over a wide ...
MALDI-TOF mass spectrometry has significantly changed the identification procedure and has to be extensively validated following AOAC and ISO 16140-6 guidelines. The Bruker MALDI Biotyper ® is now ...
The presentation will give a current overview of label-free high-throughput MALDI TOF mass spectrometry and its use in drug discovery screening. It will explain the basics of MALDI TOF mass ...
MALDI-TOF identified onychomycosis in 68 out of 100 samples, distinguishing these cases from nail psoriasis without onychomycosis (32 out of 100). An excellent correlation ...
Absolute Basics of MALDI-TOF 21 November 2022 09:00 - 22 November 2022 12:30, United Kingdom Book now Introduction This is a perfect introduction for absolute beginners to MALDI and MALDI-TOF. The ...
ANAHEIM, Calif., June 03, 2024--At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results